Publications en collaboration avec des chercheurs de University of Paris-Sorbonne (25)

2024

  1. Hospitalization of Symptomatic Patients With Heart Failure and Moderate to Severe Functional Mitral Regurgitation Treated With MitraClip: Insights From RESHAPE-HF2

    Journal of the American College of Cardiology

  2. Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure: Baseline characteristics of patients in the RESHAPE-HF2 trial and comparison to COAPT and MITRA-FR trials

    European Journal of Heart Failure, Vol. 26, Núm. 7, pp. 1608-1615

  3. Prognostic Implications of Residual Tricuspid Regurgitation Grading After Transcatheter Tricuspid Valve Repair

    JACC: Cardiovascular Interventions, Vol. 17, Núm. 12, pp. 1485-1495

  4. TRI-SCORE and benefit of intervention in patients with severe tricuspid regurgitation

    European heart journal, Vol. 45, Núm. 8, pp. 586-597

2023

  1. European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment

    European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 9, Núm. 1, pp. 1-7

2022

  1. Characteristics, management, and outcomes of patients with left-sided infective endocarditis complicated by heart failure: a substudy of the ESC-EORP EURO-ENDO (European infective endocarditis) registry

    European Journal of Heart Failure, Vol. 24, Núm. 7, pp. 1253-1265

  2. Correction to: Surgery and outcome of infective endocarditis in octogenarians: prospective data from the ESC EORP EURO-ENDO registry (Infection, (2022), 50, 5, (1191-1202), 10.1007/s15010-022-01792-0)

    Infection

  3. Surgery and outcome of infective endocarditis in octogenarians: prospective data from the ESC EORP EURO-ENDO registry

    Infection, Vol. 50, Núm. 5, pp. 1191-1202

2021

  1. Contemporary Management of Severe Symptomatic Aortic Stenosis

    Journal of the American College of Cardiology, Vol. 78, Núm. 22, pp. 2131-2143

  2. Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on Acute Admissions at the Emergency and Cardiology Departments Across Europe

    American Journal of Medicine, Vol. 134, Núm. 4, pp. 482-489

  3. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

    Journal of the American College of Cardiology, Vol. 78, Núm. 5, pp. 421-433

2020

  1. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European respiratory society (ERS)

    European Heart Journal, Vol. 41, Núm. 4, pp. 543-603

  2. Chronic kidney disease has a graded association with death and cardiovascular outcomes in stable coronary artery disease: An analysis of 21,911 patients from the CLARIFY registry

    Journal of Clinical Medicine, Vol. 9, Núm. 1

  3. Lipid-lowering therapy and low-density lipoprotein cholesterol goal achievement in patients with acute coronary syndromes: The ACS patient pathway project

    Atherosclerosis Supplements, Vol. 42, pp. e49-e58

  4. Long-term outcomes of chronic coronary syndrome worldwide: Insights from the international CLARIFY registry

    European Heart Journal, Vol. 41, Núm. 3, pp. 347-355

  5. Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC)

    European Journal of Heart Failure, Vol. 22, Núm. 9, pp. 1504-1524

2019

  1. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)

    European Respiratory Journal, Vol. 54, Núm. 3

  2. Morphine and Ticagrelor Interaction in Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: ATLANTIC-Morphine

    American Journal of Cardiovascular Drugs, Vol. 19, Núm. 2, pp. 173-183

2017

  1. Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease

    European Heart Journal, Vol. 38, Núm. 35, pp. 2649-2662

  2. Standards defining a 'heart valve centre': ESC working group on valvular heart disease and European association for cardiothoracic surgery viewpoint

    European Heart Journal